Skip to content
healthcare.dev

RABEPRAZOLE SODIUM

NDC 76420-223, rabeprazole sodium, tablet, delayed release, from Asclemed USA, Inc..

Product NDC
76420-223
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204237
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RABEPRAZOLE SODIUM20 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
76420-223-307642002233030 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-223-30)
76420-223-607642002236060 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-223-60)
76420-223-907642002239090 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-223-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9881dbb2-1ce2-4737-989f-b26720791ca5

Use it

Look up 76420-223 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.